PARAMOUNT PEPTIDES Trademark
Trademark Overview
On Monday, June 17, 2024, a trademark application was filed for PARAMOUNT PEPTIDES with the United States Patent and Trademark Office. The USPTO has given the PARAMOUNT PEPTIDES trademark a serial number of 98605459. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, April 7, 2025. This trademark is owned by Paramount Peptides, LLC. The PARAMOUNT PEPTIDES trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Diagnostic preparations for medical and veterinary purposes in the nature of peptide substrates; sanitary preparations for medical purposes.
High-purity peptides for industrial, scientific, and research purposes; chemical preparations for laboratory use; peptide substrates for use in research and diagnostic tests, other than for medical or veterinary purposes; Pharmaceutical preparations for medical and veterinary research, specifically for human and animal consumption to address medical and physical ailments.
General Information
Serial Number | 98605459 |
Word Mark | PARAMOUNT PEPTIDES |
Filing Date | Monday, June 17, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Monday, April 7, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Diagnostic preparations for medical and veterinary purposes in the nature of peptide substrates; sanitary preparations for medical purposes. |
Goods and Services | High-purity peptides for industrial, scientific, and research purposes; chemical preparations for laboratory use; peptide substrates for use in research and diagnostic tests, other than for medical or veterinary purposes; Pharmaceutical preparations for medical and veterinary research, specifically for human and animal consumption to address medical and physical ailments. |
NOT AVAILABLE | PEPTIDES |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, June 17, 2024 |
Primary Code | 001 |
First Use Anywhere Date | Wednesday, November 22, 2023 |
First Use In Commerce Date | Wednesday, November 22, 2023 |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, June 17, 2024 |
Primary Code | 005 |
First Use Anywhere Date | Wednesday, November 22, 2023 |
First Use In Commerce Date | Wednesday, November 22, 2023 |
Trademark Owner History
Party Name | Paramount Peptides, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Irvine, CA 92618 |
Trademark Events
Event Date | Event Description |
Tuesday, June 18, 2024 | NEW APPLICATION ENTERED |
Tuesday, June 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, January 7, 2025 | NON-FINAL ACTION WRITTEN |
Tuesday, January 7, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, December 19, 2024 | ASSIGNED TO EXAMINER |
Tuesday, January 7, 2025 | NON-FINAL ACTION E-MAILED |
Monday, April 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, April 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, April 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |